APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer
Part of paid clinical trials in Tucson, Arizona.
- Sponsor
- Tragara Pharmaceuticals, Inc.
- Study ID
- NCT00709826
- Phase
- PHASE2
- Status
- Completed
Conditions
- Metastatic Pancreatic Cancer
- Pancreatic Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- gemcitabine — DRUGGemcitabine: per package insert.
- placebo — DRUGplacebo: 100 mg tablets, 400 mg/day
- Erlotinib — DRUGErlotinib - per package insert.
- apricoxib — DRUGapricoxib: 100mg tablets, given orally
Study Details
This study will compare the anti-tumor efficacy of apricoxib and gemcitabine/erlotinib with placebo and gemcitabine/erlotinib in patients with advanced pancreatic cancer.
Key Dates
- First listed
- Jul 3, 2008
- Start date
- Aug 31, 2008
- Status verified
- Oct 2012
- Primary completion
- Jun 30, 2010
- Completion
- May 31, 2011
Study Design
- Enrollment
- 109 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: apricoxib + gemcitabine + erlotinib400mg apricoxib + 1000mg/m2 gemcitabine + 100mg erlotinib
- Placebo Comparator: placebo + gemcitabine + erlotinibplacebo + 1000mg/m2 gemcitabine + 100mg erlotinib
Primary Outcome Measure
Progression Free Survival [ Time Frame: Randomization then every other cycle ]
Locations (39)
Find similar trials in Tucson, AZ
By condition
By specialty
By research site
Related Studies
- Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic DisordersRecruiting · Mayo Clinic · Phoenix, Arizona
- Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer PatientsRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- Pancreatic Adenocarcinoma Gene Environment Risk StudyRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic DiseaseRecruiting · Columbia University · New York, New York